Refer a Friend

DOHERTY CLINICal trials

What is it?

Refer a friend to Doherty Clinical Trials via our DCT Engagement Community database and once they have participated in a study with us, you will receive an exclusive referral bonus.

Receive up to $500 in rewards every time a friend completes their first Doherty Clinical Trials study.

refer a friend

How does it work?

1
Tell your friend about DCTs mission and the exciting opportunities we offer.
2
Send them this link.
3
Ensure your friend enters your phone number as the referrer when expressing their interest (this step is crucial for you to receive your bonus).
4
Once your friend participates in one of our research studies, you will qualify for an additional $500.
clinical trials

Why should I introduce a friend?

You can unlock additional rewards: Whenever your friends join and complete a study, you'll earn bonus income.
Share the experience with friends: Support medical research together and you'll both be rewarded for helping. Your friends can also participate in the study with you!
Feel proud together: Making a difference in advancing medical research will give both you and your friends a sense of accomplishment!
Explore our referral terms & conditions to learn more.
November 6, 2024
Event
Dr Andrew Brockway at AusBiotech 2024

Dr Andrew Brockway's panel, 'Clinical Trials in Australia: Performance, Competitive Advantages, Challenges and Evolving Policy' at AusBiotech 2024

November 27, 2024
News
Doherty Clinical Trials at the 10th National Institutional Biosafety Committee Forum

Senior Lab Manager, Vanessa Mollard represented Doherty Clinical Trials at the forum in Canberra

June 5, 2024
In the Media
Doherty Clinical Trials on The House of Wellness

Highlighting the vital work of Doherty Clinical Trials and sharing why participants find it so rewarding.

November 16, 2023
News
Doherty Clinical Trials launches the #mRNA Platform Incubator Network

Doherty Clinical Trials launches the #mRNA Platform Incubator Network in collaboration with Moderna and other leading minds in bio-medical research

April 2, 2024
In the Media
In the News - CEO Dr Andrew Brockway interviewed by The Guardian

Delving further into the Doherty Clinical Trials experience and the purposes of human challenge trials, the article is another feature highlighting the company’s launch.